# BRM421 Ophthalmic Solution in Patients With Limbal Stem Cell Deficiency

> **NCT07422389** · — · AVAILABLE · sponsor: **BRIM Biotechnology Inc.**

## Conditions studied

- Limbal Stem Cell Deficiency (LSCD)

## Interventions

- **DRUG:** BRM421 Ophthalmic Solution, 0.06%

## Key facts

- **NCT ID:** NCT07422389
- **Lead sponsor:** BRIM Biotechnology Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07422389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07422389, "BRM421 Ophthalmic Solution in Patients With Limbal Stem Cell Deficiency". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07422389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*